Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a research note issued on Tuesday. The firm set a “hold” rating on the pharmacy operator’s stock.

Several other equities analysts also recently issued reports on WBA. Evercore ISI boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Royal Bank of Canada raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Finally, Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.26 on Tuesday. The firm has a market cap of $9.73 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The business’s 50 day moving average is $10.86 and its two-hundred day moving average is $9.77. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.66 earnings per share. Analysts forecast that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.

Institutional Trading of Walgreens Boots Alliance

Several large investors have recently added to or reduced their stakes in the company. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth about $26,000. Riverview Trust Co grew its stake in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares in the last quarter. Colonial Trust Co SC increased its holdings in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,297 shares during the period. Finally, Venturi Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $28,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.